Atsushi Sugita subentra a Koichi Takagi come Presidente e CEO di Maruho
- Koichi Takagi rimarrà Presidente del Consiglio di amministrazione -
- Koichi Takagi rimarrà Presidente del Consiglio di amministrazione -
Hanmi Pharmaceutical Co., Ltd. develops a full package strategy to potentially handle the COVID-19, including the mass production of nucleic acid vaccines (DNA/mRNA vaccine)
AlgaEnergy will become exclusive worldwide distributor of Laboratoire M2 biocontrol products and will collaborate with the Quebec company's scientists on new disease-control products for agriculture
SHENZHEN,China, Jan. 12, 2021 /PRNewswire/ -- JUD care, a leading high-tech enterprise in the field of smart medical and healthcare solutions, has obtained approval from the US Food and Drug Administration (FDA) for the portable ward sRoom ("sRoom"), a revolutionary solution for patient isolation that enables hospitals to quickly set up emergency isolation rooms.
The operation creates the most vertically integrated group in the bioplastics industry and allows the Italian B-Corp to further expand into Northern/Eastern Europe, North America and Australia
TOKYO, Jan. 12, 2021 /PRNewswire/ -- The growing trend toward electric vehicles is spurring materials suppliers like Polyplastics Co., Ltd., a leading global supplier of engineering plastics, to position its innovative resin products for use in Advanced Driver-Assistance System(ADAS) parts that enable autonomous driving. The company's DURANEX(R) PBT and DURAFIDE(R) PPS materials--targeted for sensors in radar and camera bracket systems--show great promise in delivering low warpage, dimensional st...
SEOUL, South Korea, Jan. 11, 2021 /PRNewswire/ -- Yuyu Pharma (CEO Robert Wonsang Yu, KRX: 000220) received Compliance Program (CP) Rating of "A" from the Korea Fair Trade Commission (FTC).
MONTREAL, Jan. 7, 2021 /PRNewswire/ -- Caprion-HistoGeneX, a leading global contract research laboratory services provider backed by Arsenal Capital Partners, announced today the acquisition of Clinical Logistics Inc. ("CLI"), a Virtual Central Specimen Management CRO based in Halifax, Canada. The acquisition enables Caprion-HistoGeneX to broaden its specimen logistics services to support the global clinical trial needs of its pharma and biotech customers better. Focused on critical specialty spe...
SHANGHAI and TAIPEI, Jan. 7, 2021 /PRNewswire/ -- Hongkong Winhealth Pharma Group (Winhealth Pharma) and Taiwan TWi Biotechnology, Inc. (TWiB) announced strategic partnership granting Winhealth Pharma exclusive right to develop and commercialize rare disease asset AC-203 in mainland China, Hong Kong and Macao for indications including hereditary epidermolysis bullosa (EB), bullous pemphigoid and other skin diseases.
Acquisition will expand Ascend's flame-retardant portfolio and European footprint
STOCKHOLM and HANGZHOU, China, Dec. 31, 2020 /PRNewswire/ -- Hongkong WinHealth Pharma Group CO., Ltd and Immedica Pharma AB, today announce that they have entered an agreement under which WinHealth gains the exclusive commercial rights to Ravicti® (glycerol phenylbutyrate), in a territory covering the Greater China Area, South Korea, Singapore, Vietnam, Indonesia, Malaysia, Philippines and Thailand.
Recognized for adapting and implementing outstanding family-friendly policies for employees
Con le modifiche alla procedura di payback per il 2018 e 2019 si rischia una nuova stagione di contenziosi
Followed by Russia, Indonesia, and Korea, the second phase of the COVID-19 clinical trial was approved in Italy on Friday, December 18, 2020.
GRONINGEN, Paesi Bassi, 17 dicembre 2020 /PRNewswire/ -- Il Presidente e CEO di Plasticase Inc., José Chagnon e Herman Vaszlovsky, Amministratore Delegato di NANUK EU bv, hanno oggi annunciato la nomina di Ken Adriaenssens a Direttore Vendite e Strategia Commerciale dell'EMEA. Plasticase Inc. è il produttore di valigie protettive professionali NANUK con sede in Quebec, Canada.
SHIJIAZHUANG, China, Dec. 17, 2020 /PRNewswire/ -- Yiling Pharmaceutical discloses on Wednesday that it has received the Approval of Registration approved and issued by the Medicines Control Authority of Zimbabwe, which indicates that the Company's patented product of "Lianhua Qingwen Capsules" meets Zimbabwe's registration standards for complementary medicine.
GRONINGEN, The Netherlands, Dec. 15, 2020 /PRNewswire/ -- President and CEO of Plasticase Inc., José Chagnon and Herman Vaszlovsky, Managing Director of NANUK EU bv, today announced the appointment of Ken Adriaenssens as EMEA Director of Sales and Commercial Strategy. Plasticase Inc. is the Quebec, Canada-based manufacturer of NANUK Professional Protective Cases.
GENEVA and CASTRES , France, Dec. 14, 2020 /PRNewswire/ -- The EspeRare Foundation and the Pierre Fabre group announced today that they have entered into a license and development collaboration agreement for the development and commercialization of ER-004, a prenatal treatment for XLHED (X-linked Hypohidrotic Ectodermal Dysplasia), a rare, debilitating congenital disease. The next clinical study is expected to start in 2021 and will aim at qualifying and registering what may become the first appr...
New interview with Prof. Güralp Ceyhan, MD. details advancements in pancreatic cancer therapy at Acibadem Maslak and Altunizade Hospital
